Vontobel Holding
CRSP icon

Vontobel Holding’s CRISPR Therapeutics CRSP Stock Holding History

Vontobel Holding’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Sell
19,124
-704
-4% -$37.1K ﹤0.01% 803
2026
Q1 		$943K Buy
19,828
+6,826
+52% +$360K ﹤0.01% 671
2025
Q4 		$682K Buy
13,002
+8,301
+177% +$497K ﹤0.01% 886
2025
Q3 		$305K Buy
+4,701
New +$270K ﹤0.01% 1102
2025
Q2 		– Sell
-12,741
Closed -$434K – 1270
2025
Q1 		$434K Sell
12,741
-2,327
-15% -$98.6K ﹤0.01% 827
2024
Q4 		$593K Sell
15,068
-1,889
-11% -$89.2K ﹤0.01% 749
2024
Q3 		$797K Buy
16,957
+600
+4% +$30.4K ﹤0.01% 652
2024
Q2 		$883K Sell
16,357
-1,450
-8% -$83.9K ﹤0.01% 595
2024
Q1 		$1.21M Sell
17,807
-47
-0.3% -$3.37K 0.01% 531
2023
Q4 		$1.12M Sell
17,854
-549
-3% -$30.4K 0.01% 564
2023
Q3 		$835K Sell
18,403
-497
-3% -$25.7K 0.01% 625
2023
Q2 		$1.06M Buy
18,900
+249
+1% +$14.1K 0.01% 587
2023
Q1 		$844K Sell
18,651
-2,681
-13% -$130K 0.01% 631
2022
Q4 		$836K Buy
21,332
+2,643
+14% +$140K 0.01% 617
2022
Q3 		$1.22M Sell
18,689
-1,566
-8% -$113K 0.01% 503
2022
Q2 		$1.28M Sell
20,255
-1,105
-5% -$65K 0.01% 486
2022
Q1 		$1.37M Sell
21,360
-5,119
-19% -$321K 0.01% 534
2021
Q4 		$2.09M Buy
26,479
+4,664
+21% +$407K 0.02% 426
2021
Q3 		$2.44M Buy
21,815
+3,144
+17% +$395K 0.02% 406
2021
Q2 		$2.81M Buy
+18,671
New +$2.27M 0.02% 372

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vontobel Holding's CRSP Position: Q2 2026 in Review

Vontobel Holding reduced its CRISPR Therapeutics (CRSP) stake by 3.6% in Q2 2026, selling an estimated $37.1K and leaving 19,124 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #803.

Vontobel Holding first reported a position in CRSP in Q2 2021 and has held it in 20 quarters since. The position peaked at $2.81M in Q2 2021. 524 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • Vontobel Holding held 19,124 shares of CRISPR Therapeutics worth $1.04M as of Q2 2026.
  • Vontobel Holding sold 704 CRISPR Therapeutics shares in Q2 2026, an estimated $37.1K.
  • CRISPR Therapeutics made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #803 holding.
  • Vontobel Holding first reported a position in CRISPR Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Vontobel Holding's CRISPR Therapeutics position peaked at $2.81M in Q2 2021.
  • 524 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.